Considerations for Integrating COVID-19 Vaccination into Immunisation Programmes and Primary Health Care for 2022 and Beyond

LOOK AT THIS IF YOU'RE INTERESTED IN:

Understanding the key considerations for integrating COVID-19 vaccination into immunisation programme services, primary health care, and other relevant health services.

HOW YOU CAN USE THIS MATERIAL:

National and subnational public health planners, immunisation programme managers responsible for COVID-19 vaccination and/or essential programmes on immunisation (EPI), those overseeing PHC programmes, and global, regional and country level partners and stakeholders can use this guidance to understand the risks and benefits of COVID-19 vaccination integration and to identify approaches for integrated service delivery.

OVERVIEW:

WHO and UNICEF developed this guidance, which lays out key programmatic considerations – including risks and benefits – of moving from conducting mass COVID-19 vaccination campaigns to integrating COVID-19 vaccination into immunisation programmes, primary health care (PHC), and other relevant health services for 2022 and beyond. Country experiences with COVID-19 vaccination integration are also summarized.

You May Also Like

Linked Country Case Study: Strengthening Indonesia’s National Immunisation Program

The Linked Immunisation Action Network has supported Indonesia in addressing critical immunisation challenges through peer-to-peer learning and tailored interventions. Amidst COVID-19-related backsliding (DTP3 coverage dropped from 85% in 2019 to 67% in 2021), Indonesia engaged in collaborative learning exchanges to tackle human resource gaps, data system limitations, and subnational inequities. Key initiatives included a study … Read More

Download
File size: 4.54M

Socioeconomic-related inequities in child immunisation: horizontal and vertical dimensions for policy insights

A study in Health Economics Review investigates the economic and equity impacts of expanding immunisation programs in low- and middle-income countries (LMICs), focusing on the cost-effectiveness of introducing new vaccines. The research highlights that while scaling up immunisation efforts requires significant investment, the long-term benefits—such as reduced disease burden, healthcare savings, and improved productivity—justify the … Read More